Microspherophakia-metaphyseal dysplasia syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2551OMIM:157151Q87.5
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Microspherophakia-metaphyseal dysplasia syndrome (also known as metaphyseal dysplasia with microspherophakia) is an extremely rare genetic disorder characterized by the combination of ocular abnormalities and skeletal anomalies. The condition primarily affects the eyes and the skeletal system. Microspherophakia refers to a small, spherically shaped lens of the eye, which can lead to significant visual problems including severe myopia (nearsightedness), lens subluxation (partial dislocation of the lens), and secondary glaucoma due to pupillary block. The skeletal component involves metaphyseal dysplasia, which is an abnormality in the growth regions (metaphyses) of long bones, potentially leading to short stature and characteristic radiographic findings in the limbs. The condition has been described in only a small number of families in the medical literature. Affected individuals may present in childhood with visual difficulties and skeletal abnormalities that become apparent on radiographic evaluation. Additional features that have been reported include brachydactyly (short fingers) and joint stiffness. Management is primarily symptomatic and supportive. Ophthalmologic care is essential and may include corrective lenses, monitoring for glaucoma, and surgical intervention if lens subluxation or glaucoma becomes problematic. Orthopedic follow-up may be needed to monitor skeletal growth and development. There is currently no specific curative treatment for this syndrome, and care focuses on addressing individual symptoms as they arise.

Also known as:

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Microspherophakia-metaphyseal dysplasia syndrome.

View clinical trials →

No actively recruiting trials found for Microspherophakia-metaphyseal dysplasia syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Microspherophakia-metaphyseal dysplasia syndrome community →

No specialists are currently listed for Microspherophakia-metaphyseal dysplasia syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Microspherophakia-metaphyseal dysplasia syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Microspherophakia-metaphyseal dysplasia syndromeForum →

No community posts yet. Be the first to share your experience with Microspherophakia-metaphyseal dysplasia syndrome.

Start the conversation →

Latest news about Microspherophakia-metaphyseal dysplasia syndrome

No recent news articles for Microspherophakia-metaphyseal dysplasia syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Microspherophakia-metaphyseal dysplasia syndrome

What is Microspherophakia-metaphyseal dysplasia syndrome?

Microspherophakia-metaphyseal dysplasia syndrome (also known as metaphyseal dysplasia with microspherophakia) is an extremely rare genetic disorder characterized by the combination of ocular abnormalities and skeletal anomalies. The condition primarily affects the eyes and the skeletal system. Microspherophakia refers to a small, spherically shaped lens of the eye, which can lead to significant visual problems including severe myopia (nearsightedness), lens subluxation (partial dislocation of the lens), and secondary glaucoma due to pupillary block. The skeletal component involves metaphyseal

How is Microspherophakia-metaphyseal dysplasia syndrome inherited?

Microspherophakia-metaphyseal dysplasia syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Microspherophakia-metaphyseal dysplasia syndrome typically begin?

Typical onset of Microspherophakia-metaphyseal dysplasia syndrome is childhood. Age of onset can vary across affected individuals.